|
1.
|
Rich JN: Cancer stem cells in radiation
resistance. Cancer Res. 67:8980–8984. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Rosen JM and Jordan CT: The increasing
complexity of the cancer stem cell paradigm. Science.
324:1670–1673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Baumann M, Krause M and Hill R: Exploring
the role of cancer stem cells in radioresistance. Nat Rev Cancer.
8:545–554. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Eramo A, Ricci-Vitiani L, Zeuner A, et al:
Chemotherapy resistance of glioblastoma stem cells. Cell Death
Differ. 13:1238–1241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Winquist RJ, Boucher DM, Wood M and Furey
BF: Targeting cancer stem cells for more effective therapies:
Taking out cancer’s locomotive engine. Biochem Pharmacol.
78:326–334. 2009.PubMed/NCBI
|
|
7.
|
Zhang Q, Shi S, Yen Y, et al: A
subpopulation of CD133+ cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
|
|
8.
|
Liu G, Yuan X, Zeng Z, et al: Analysis of
gene expression and chemoresistance of CD133+ cancer
stem cells in glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Jin Y, Bin ZQ, Qiang H, et al: ABCG2 is
related with the grade of glioma and resistance to mitoantone, a
chemotherapeutic drug for glioma. J Cancer Res Clin Oncol.
135:1369–1376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chiba T, Kamiya A, Yokosuka O, et al:
Cancer stem cells in hepatocellular carcinoma: Recent progress and
perspective. Cancer Lett. 286:145–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Chiba T, Kita K, Zheng Y, et al: Side
population purified from hepatocellular carcinoma cells harbors
cancer stem cell-like properties. Hepatology. 44:240–251. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Yin S, Li J, Hu C, et al: CD133 positive
hepatocellular carcinoma cells possess high capacity for
tumorigenicity. Int J Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Ma S, Chan K, Hu L, et al: Identification
and characterization of tumorigenic liver cancer stem/progenitor
cells. Gastroenterology. 132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yang W, Yan HX, Chen L, et al:
Wnt/beta-catenin signaling contributes to activation of normal and
tumorigenic liver progenitor cells. Cancer Res. 68:4287–4295. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yamashita T, Ji J, Budhu A, et al:
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating
cells with stem/progenitor cell features. Gastroenterology.
136:1012–1024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Suetsugu A, Nagaki M, Aoki H, et al:
Characterization of CD133+ hepatocellular carcinoma
cells as cancer stem/progenitor cells. Biochem Biophys Res Commun.
351:820–824. 2006.
|
|
17.
|
Yin AH, Miraglia S, Zanjani ED, et al:
AC133, a novel marker for human hematopoietic stem and progenitor
cells. Blood. 90:5002–5012. 1997.PubMed/NCBI
|
|
18.
|
Richardson GD, Robson CN, Lang SH, et al:
CD133, a novel marker for human prostatic epithelial stem cells. J
Cell Sci. 117:3539–3545. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Corbeil D, Roper K, Hellwig A, et al: The
human AC133 hematopoietic stem cell antigen is also expressed in
epithelial cells and targeted to plasma membrane protrusions. J
Biol Chem. 275:5512–5520. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Uchida N, Buck DW, He D, et al: Direct
isolation of human central nervous system stem cells. Pro Natl Acad
Sci USA. 97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
22.
|
Bruno S, Bussolati B, Grange C, et al:
CD133+ renal progenitor cells contribute to tumor
angiogenesis. Am J Pathol. 169:2223–2235. 2006.
|
|
23.
|
O’Brien CA, Pollett A, Gallinger S, et al:
A human colon cancer cell capable of initiating tumour growth in
immunodeficient mice. Nature. 445:106–110. 2007.PubMed/NCBI
|
|
24.
|
Collins AT, Berry PA, Hyde C, et al:
Prospective indentification of tumorigenic prostate cancer stem
cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Song W, Li H, Tao K, et al: Expression and
clinical significance of the stem cell marker CD133 in
hepatocellular carcinoma. Int J Clin Pract. 62:1212–1218. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Peichev M, Naiyer AJ, Pereira D, et al:
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells
identifies a population of functional endothelial precursors.
Blood. 95:952–958. 2000.
|
|
27.
|
Xu Y, Wang Z, Wang J, et al:
Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma
cell proliferation. Oncol Res. 18:359–364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Tomuleasa C, Soritau O, Rus-Ciuca D, et
al: Isolation and characterization of hepatic cancer cells with
stem-like properties from hepatocellular carcinoma. J
Gastrointestin Liver Dis. 19:61–67. 2010.PubMed/NCBI
|
|
29.
|
Chen YW, Chen KH, Huang PI, et al:
Cucurbitacin I suppressed stem-like property and enhanced
radiation-induced apoptosis in head and neck squamous
carcinoma-derived CD44+ALDH1+ cells. Mol
Cancer Ther. 9:2879–2892. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Shafee N, Smith CR, Wei S, et al: Cancer
stem cells contribute to cisplatin resistance in Brca1/p53-mediated
mouse mammary tumors. Cancer Res. 68:3243–3250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Reya T, Morrison SJ, Clarke MF, et al:
Stem cell, cancer, cancer stem cells. Nature. 414:105–111. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Clark MF, Dick JE, Dirks PB, et al: Cancer
stem cells - perspectives on current status and future directions:
AACR workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar
|
|
34.
|
Mizrak D, Brittan M and Alison MR: CD133:
molecule of the moment. J Pathol. 214:3–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Zhang J, Luo N, Luo Y, et al: MicroRNA-150
inhibits human CD133-positive liver cancer stem cells through
negative regulation of the transcription factor c-MyB. Int J Oncol.
40:747–756. 2012.PubMed/NCBI
|
|
36.
|
Korkaya H and Wicha MS: Selective
targeting of cancer stem cells: a new concept in cancer
therapeutics. BioDrugs. 21:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Rappa G, Fodstad O and Lorico A: The stem
cell-associated antigen CD133 (promini-1) is a molecular
therapeutic target for metastatic melanoma. Stem Cells.
26:3008–3017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Wang CH, Chiou SH, Chou CP, et al:
Photothermolysis of glioblastoma stem-like cells targeted by carbon
nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine.
7:69–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Yang ZF, Ho DW, Ng MN, et al: Significance
of CD90+ cancer stem cells in human liver cancer. Cancer
Cell. 13:153–166. 2008.
|
|
40.
|
Yang W, Wang C, Lin Y, et al:
OV6+ tumor-initiating cells contribute to tumor
progression and invasion in human hepatocellular carcinoma. J
Hepatol. 57:613–620. 2012.
|
|
41.
|
Uchida N, Sutton RE, Friera AM, et al:
HIV, but not murine leukemia virus, vectors mediated high
efficiency gene transfer into freshly isolated G0/G1 human
hematopoietic stem cells. Proc Natl Acad Sci USA. 95:11939–11944.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Eyler CE and Rich JN: Survival of the
fittest: cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
